E. Nadal - Concepedia

Author

E. Nadal

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Also Known As

E Nadal, E. Nadal, Elisabet Nadal, Nadal E.

Publications

830

Citations

H-Index

Concepts

All Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Universitat de Barcelona Hammersmith Hospital Imperial College London Hospital Clínic de Barcelona

About

E. Nadal is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	451
2	Health Sciences	3	3	142
3	Blood Transplantation	3	3	142
4	Cell Biology	2	2	129
5	Biochemistry	1	1	97

E. Nadal

Publications

738

Citations

H-Index

Page 1

	Year	Citations
Smoldering multiple myeloma: natural history and recognition of an evolving type Laura Rosiñol, Joan Bladé, Jordi Esteve, British Journal of Haematology	2003	149
Localization of monoamine oxidases in human peripheral tissues Josep Saura, E. Nadal, B. van den Berg, Life Sciences BiochemistryMedicineMonoamine NeurotransmittersHuman Peripheral TissuesDopamine	1996	97
Danazol treatment of idiopathic myelofibrosis with severe anemia. Francisco Cervantes, Juan Carlos Hernández‐Boluda, E. Nadal, PubMed	2000	72
Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma Evangelos Terpos, Marianna Politou, Richard Szydlo, Leukemia Cell Replacement TherapyOsteoporosisOrthopaedic SurgeryRegenerative MedicineBone Marrow Failure	2004	66
Increased frequencies of CD4+CD25high Tregs correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia E. Nadal, Marina Garín, Jaspal Kaeda, Leukemia Hematological MalignancyChronic Myeloid LeukemiaCd4+cd25high Tregs CorrelateTransplantationMarrow Transplantation	2007	63
High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission E. Nadal, Eva Giné, Joan Bladé, Bone Marrow Transplantation Hematological MalignancyCell TherapyTransplantationMarrow TransplantationMedicine	2004	59
Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy Maria Paola Simula, Sarah Marktel, Claudio Fozza, Leukemia Hematological MalignancyChronic Myeloid LeukemiaTransplantationMarrow TransplantationOncology	2007	51
Serial quantification of lymphoid and myeloid mixed chimerism using multiplex PCR amplification of short tandem repeat-markers predicts graft rejection and relapse, respectively, after allogeneic transplantation of CD34+ selected cells from peripheral blood Francesc Fernández‐Avilés, Álvaro Urbano-Ispizúa, Marta Aymerich, Leukemia Short Tandem Repeat-markersTransplantationMedicineStem Cell TransplantationImmunology	2003	50
Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions E. Nadal, Alexis Fowler, Ed Kanfer, Experimental Hematology Cell TherapyTransplantationImmunosuppressive TherapyImmunologyHematology	2004	33
Factors for graft‐<i>versus</i>‐host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose Claudio Fozza, Richard Szydlo, Marwa M. Abdel-Rehim, British Journal of Haematology	2007	27

Page 1